Improving pharmacovigilance in Europe: TPMT genotyping and phenotyping in the UK and Spain

Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease

(2008) A. ANSARI et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The effect of thiopurine drugs on DNA methylation in relation to TPMT expression

(2008) L.A. Hogarth et al.   BIOCHEMICAL PHARMACOLOGY

Genetic Polymorphism of Inosine Triphosphate Pyrophosphatase Is a Determinant of Mercaptopurine Metabolism and Toxicity During Treatment for Acute Lymphoblastic Leukemia

(2008) G Stocco et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Thiopurine S-methyltransferase activity in three major Asian populations: a population-based study in Singapore

(2008) Shirley Kow Yin Kham et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism

(2008) U. Boonsrirat et al.   LUPUS

Ethnic variation of thiopurine S-methyltransferase activity: a large, prospective population study

(2008) Sheldon C Cooper et al.   PHARMACOGENOMICS

Towards an economic evidence base for pharmacogenetics: consideration of outcomes is key

(2007) Katherine Payne   PHARMACOGENOMICS